Bloomberg Businessweek Daily: Apple Growth Decelerates (Podcast)

Apple reported decelerating September-quarter sales growth, down from 16% in the June quarter, while China revenue missed estimates; this was its first earnings report since John Ternus became CEO. Anthropic disclosed a twelve-fold increase in quarterly revenue and plans to spend more than $895 billion in the coming years. Marvell agreed to acquire Lumentum in a deal valued at $115 billion.

Analysis

The key issue is whether slowing Apple growth is a China-specific stumble or evidence that mature-device demand is becoming harder to reaccelerate. One quarter does not establish either; the September-region detail, guidance, and product mix matter more than the headline growth comparison. If China weakness persists, it can pressure expectations for the broader Apple ecosystem, but suppliers’ exposure should not be assumed without current revenue breakdowns.

Anthropic’s reported revenue acceleration is not yet proof that its spending plans translate into durable supplier revenue. The amount, timing, and nature of the intended spend are unspecified; distinguish binding commitments from ambitions and revenue from cash collection. If deployment scales, compute and optical-networking demand could benefit, but funding and utilization are potential constraints.

For MRVL and LITE, the strategic case may be broader than near-term earnings: combining relevant networking and optical capabilities could offer a more integrated AI-infrastructure proposition. Conversely, deal financing, integration, customer concentration concerns, and regulatory review can overwhelm the synergy story. The stated transaction value alone does not establish value creation or closing certainty.

Near term, deal terms and Apple guidance are the catalysts; over 1–3 months, watch China demand indicators and transaction financing/regulatory milestones. Over 6–18 months, the test is whether AI infrastructure spending converts into realized, monetizable demand. Contrarian point: the market may overread both Apple’s single-quarter deceleration and Anthropic’s growth rate; neither trend is established without follow-through.

Key Decisions for Investors

• AAPL: Avoid adding to directional exposure solely on this report. Treat persistent China weakness as a hedge trigger; verify regional revenue, guidance, and product mix next quarter. A recovery in China sales or stable forward guidance would falsify the cautious near-term view.
• ANT: Do not extrapolate the reported growth rate into a valuation or supplier-demand forecast. Track the spending breakdown, funding, and conversion to collected revenue; treat inability to fund or deploy the planned spend as the downside trigger.
• MRVL/LITE: Wait for definitive consideration, financing, closing conditions, and regulatory details before taking merger-arbitrage exposure. If the deal proceeds, monitor customer retention and integration milestones; a financing change, material delay, or adverse regulatory action weakens the thesis.
• Potential relative-value watch: if Apple’s next report confirms China-led weakness while AI spending converts into actual orders, consider reducing AAPL against a diversified AI-infrastructure basket rather than making a single-name supplier bet. Confirm supplier exposure and relative valuation first.